Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

Share Price is delayed by 15 minutes
Get Live Data
1,175.00    -5.00 (-0.42%)
Bid:
1,170.00
Ask:
1,173.00
Spread: 3.00 (0.256%)
Market Cap: £817.13m
CVSG Live PriceLast checked at - London Stock Exchange

Intraday CVS Group Share Chart

Option exercise and block listing update

31 Jan 2020 17:47

RNS Number : 6508B
CVS Group plc
31 January 2020
 

CVS Group plc

("CVS" or the "Company")

Exercise of Options and Confirmation of Cancellation of Block Listing

CVS, one of the UK's leading providers of integrated veterinary services for small and large animals, confirms that certain employees have exercised options under the Company's Save As You Earn (SAYE) 2020 scheme (the "SAYE Exercise") totalling 66,249 ordinary shares of 0.2 pence each ("Ordinary Shares") during January.

The SAYE Exercise was satisfied out of the Company's existing Employee Benefit Trust ("EBT") which was first announced on 28 February 2017. As at the date of this announcement, the remaining number of ordinary shares held by the EBT is 72,519.

The Company also announces that its 2015/2018 Save as You Earn option scheme has closed and, as a result, the block listing associated with it has been cancelled. Since the block listing interim review dated 24 June 2019, the Company issued a total of 24,335 shares in satisfaction of the exercise of SAYE options. All such issuance has been previously announced. The Company has no other block listings.

The Company's total issued share capital at the date of this announcement therefore remains unchanged at 70,654,959 Ordinary Shares each carrying one voting right.

The Company does not hold any Ordinary Shares in treasury. The total number of voting rights is therefore 70,654,959. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Name of applicant:

CVS Group plc

Name of scheme:

2015/2018 Save as You Earn Scheme

Period of return:

From:

23 June 2019

To:

30 December 2019

Balance of unallotted securities under scheme(s) from previous return:

136,632

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

Nil

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

24,335

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

112,297

Subsequent cancellation:

(112,297)

Equals: Remaining balance under block listing

Nil

 

Contacts:

CVS Group Plc Tel: 01379 644288

Richard Fairman, Chief Executive Officer

David Harris, Company Secretary

 

N+1 Singer (Nominated Adviser & Broker) Tel: 020 7496 3000

Aubrey Powell (Corporate Finance)

Rachel Hayes (Corporate Broking)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCSDMFWFESSELF
Date   Source Headline
31st Mar 20257:00 amRNSTotal Voting Rights
28th Mar 20253:03 pmRNSPDMR Dealing
13th Mar 20254:17 pmRNSStandard form for notification of major holdings
28th Feb 20259:57 amRNSTotal Voting Rights
27th Feb 20257:00 amRNSInterim Results
6th Feb 20259:24 amRNSStandard form for notification of major holdings
31st Jan 20257:00 amRNSTotal Voting Rights
30th Jan 20257:00 amRNSHalf Year Trading Update
13th Jan 20257:00 amRNSBlock listing Interim Review
7th Jan 20257:00 amRNSDirector/PDMR Shareholding
31st Dec 202410:52 amRNSTotal Voting Rights
29th Nov 20247:00 amRNSTotal Voting Rights
26th Nov 20241:59 pmRNSGrant of Options & PDMR Dealing
21st Nov 20244:05 pmRNSStandard form for notification of major holdings
20th Nov 202412:51 pmRNSResult of AGM
20th Nov 20247:00 amRNSAGM Statement and Trading Update
4th Nov 20249:18 amRNSStandard form for notification of major holdings
31st Oct 202411:35 amRNSExercise of Options and Total Voting Rights
30th Oct 20244:11 pmRNSStandard form for notification of major holdings
21st Oct 202410:42 amRNSPosting of Annual Report and Notice of AGM
16th Oct 202412:14 pmRNSStandard form for notification of major holdings
14th Oct 20242:34 pmRNSnotification of major holdings
11th Oct 20245:28 pmRNSHolding(s) in Company
4th Oct 20245:11 pmRNSLong Term Incentive Plan Awards and PDMR Dealing
3rd Oct 20247:00 amRNSNotification of major holdings
1st Oct 20247:00 amRNSTotal Voting Rights
26th Sep 20247:00 amRNSFinal results for the year ended 30 June 2024
2nd Sep 20242:45 pmRNSTotal Voting Rights
31st Jul 20247:00 amRNSTotal Voting Rights
30th Jul 20249:42 amRNSHolding(s) in Company
25th Jul 20247:00 amRNSTrading Statement
12th Jul 20247:00 amRNSBlock Listing Interim Review
11th Jul 20241:55 pmRNSPDMR Dealing
28th Jun 20247:00 amRNSExercise of Options and Total Voting Rights
27th Jun 20242:53 pmRNSDirector/PDMR Shareholding
24th Jun 20244:48 pmRNSPDMR Dealing
18th Jun 20241:35 pmRNSDirectorate Change
31st May 20247:00 amRNSTotal Voting Rights
23rd May 20247:12 amRNSResponse to CMA announcement
21st May 20247:00 amRNSDisposal of non-core operations
1st May 20247:00 amRNSAppointment of Non-executive Chair
30th Apr 20247:00 amRNSTotal Voting Rights
11th Apr 20245:48 pmRNSStandard form for notification of major holdings
8th Apr 20247:00 amRNSNotice of Cyber Incident
28th Mar 20244:07 pmRNSExercise of Options and Total Voting Rights
12th Mar 20248:06 amRNSResponse to CMA update
29th Feb 20247:00 amRNSExercise of Options and Total Voting Rights
29th Feb 20247:00 amRNSInterim Results
5th Feb 202411:02 amRNSStandard form for notification of major holdings
31st Jan 20247:00 amRNSExercise of Options and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.